Stockreport
Should You Be Confident in Vertex Pharmaceuticals Incorporated's (VRTX) Long-Term Outlook? [Yahoo! Finance]
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
A copy of the letter can be downloaded here . The portfolio underperformed in the quarter due to stock selection. The composite returned 5.02%, net of fees, compared to 7.62% for the MSCI AC World Net Index. In addition, please check the fund's top five holdings to know its best picks in 2025. In its third-quarter 2025 investor letter, Hardman Johnston Global Equity Strategy highlighted stocks such as Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ). Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a biotechnology company focusing on developing and commercializing therapies for treating cystic fibrosis (CF). The one-month return of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was 8.76%, and its shares gained 15.91% of their value over the last 52 weeks. On December 26, 2025, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock closed at $462.90 per share, with a market capitalization of $118.683 billion. Hardman Johnston Global Equity Strategy stated the following r
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VRTX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VRTX alerts
VRTX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
NEWS
NEWS
- Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Leerink Partners from $456.00 to $525.00. They now have an "outperform" rating on the stock.[MarketBeat]
- Forget Moderna Stock, This is a Much Better Buy [Yahoo! Finance][Yahoo! Finance]
- Why a 63% Vertex Selloff Didn't Scare Off a New $13 Million Investor [Yahoo! Finance][Yahoo! Finance]
- Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress [Yahoo! Finance][Yahoo! Finance]
- Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12[Business Wire]
- More
VRTX
SEC Filings
SEC Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- VRTX's page on the SEC website
- More